VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $610 | -7.2% | 24,850 | -12.0% | 0.05% | -10.5% |
| Q1 2023 | $657 | -9.1% | 28,250 | -1.1% | 0.06% | -13.6% |
| Q4 2022 | $723 | -99.9% | 28,550 | -15.2% | 0.07% | +3.1% |
| Q3 2022 | $649,000 | -27.5% | 33,650 | -4.3% | 0.06% | -22.0% |
| Q2 2022 | $895,000 | -6.6% | 35,150 | -5.6% | 0.08% | +9.3% |
| Q1 2022 | $958,000 | -40.6% | 37,250 | -3.4% | 0.08% | -40.0% |
| Q4 2021 | $1,614,000 | -3.8% | 38,550 | 0.0% | 0.12% | -11.3% |
| Q3 2021 | $1,678,000 | -12.5% | 38,550 | -4.9% | 0.14% | -7.8% |
| Q2 2021 | $1,917,000 | -9.8% | 40,550 | -2.2% | 0.15% | -16.4% |
| Q1 2021 | $2,125,000 | +246.7% | 41,450 | +81.0% | 0.18% | +210.2% |
| Q4 2020 | $613,000 | +40.0% | 22,900 | +79.6% | 0.06% | +22.9% |
| Q3 2020 | $438,000 | – | 12,750 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |